Group 1 - The core viewpoint of the report indicates that Smoore International's revenue increased by 18% year-on-year in the first half of the year, while net profit after tax decreased by 2.5%, which is roughly in line with expectations [1] - The company is expected to see a slight improvement in revenue growth for the full year, but profit margins are anticipated to remain under pressure [1] - Due to the weak profitability of Smoore International, the earnings per share estimates for the next two years have been lowered by 5% and 10%, respectively, and the target price has been reduced by 6% to HKD 8.7, maintaining an "underperform" rating [1]

Core Viewpoint - Smoore International (06969) experienced a significant stock price fluctuation, initially rising over 8% before closing up 6.25%, but later fell by 5.88% to HKD 22.08 with a trading volume of HKD 683 million [1] Financial Performance - For the first half of 2025, Smoore International reported revenue of RMB 6.013 billion, representing a year-on-year increase of 18.3% [1] - Adjusted profit for the period was RMB 737 million, a decrease of 2.1% year-on-year [1] - Net profit for the period was RMB 492 million, reflecting a significant year-on-year decline of 27.96% [1] Dividend Announcement - In celebration of the company's fifth anniversary since its listing, the board declared an interim dividend of HKD 0.20 per share for the six months ending June 30, 2025, compared to HKD 0.05 per share in the same period last year [1] Analyst Insights - According to a report from Bank of America Securities, the company is expected to see a slight improvement in annual revenue growth, but profit margins are anticipated to remain under pressure [1]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is experiencing a recovery in the European electronic vaporization market, and the HNB (Heat-not-Burn) segment is expected to release profit elasticity [8] - The company's revenue for the first half of 2025 reached 6.013 billion yuan, a year-on-year increase of 18.3%, aligning with forecast values and exceeding initial high single-digit expectations [8] - The HNB market is in a rapid growth phase, with the company collaborating with British American Tobacco on new products, indicating potential for future profit contributions [8] Financial Summary - Total revenue projections for the company are as follows: - 2023A: 11.177 billion yuan - 2024A: 11.799 billion yuan - 2025E: 13.722 billion yuan - 2026E: 16.166 billion yuan - 2027E: 18.395 billion yuan - Year-on-year growth rates are projected at (8.06)%, 5.56%, 16.30%, 17.81%, and 13.79% respectively [1] - Net profit attributable to the parent company is forecasted as: - 2023A: 1.645 billion yuan - 2024A: 1.303 billion yuan - 2025E: 1.329 billion yuan - 2026E: 2.217 billion yuan - 2027E: 2.891 billion yuan - Year-on-year growth rates are projected at (34.47)%, (20.78)%, 1.96%, 66.84%, and 30.40% respectively [1] - The latest diluted EPS (Earnings Per Share) is projected as follows: - 2023A: 0.27 yuan - 2024A: 0.21 yuan - 2025E: 0.21 yuan - 2026E: 0.36 yuan - 2027E: 0.47 yuan [1] - The P/E (Price-to-Earnings) ratios at current price and latest diluted EPS are: - 2023A: 80.56 - 2024A: 101.69 - 2025E: 99.73 - 2026E: 59.78 - 2027E: 45.84 [1]

Core Viewpoint - Bank of America Securities reports that Smoore International (06969) experienced an 18% year-on-year increase in revenue for the first half of the year, while net profit after tax fell by 2.5%, which is roughly in line with expectations [1] Financial Performance - Smoore International's revenue growth for the full year is expected to improve slightly, but profit margins are anticipated to remain under pressure [1] - The bank has lowered its earnings per share estimates for the company by 5% and 10% for the current and next year, respectively [1] Target Price Adjustment - The target price for Smoore International has been reduced by 6% to HKD 8.7 [1] - The rating has been reaffirmed as "underperform" [1]

Core Viewpoint - Bank of America Securities reports that Smoore International (06969) experienced an 18% year-on-year increase in revenue for the first half of the year, while after-tax net profit declined by 2.5%, which is roughly in line with expectations [1] Group 1 - The company is expected to see a slight improvement in revenue growth for the full year, but profit margins are anticipated to remain under pressure [1] - Due to the weak profitability of Smoore International, the earnings per share estimates for the next two years have been lowered by 5% and 10% respectively [1] - The target price has been reduced by 6% to HKD 8.7, and the rating has been reiterated as "underperform" [1]

Core Viewpoint - Smoore International (06969) experienced a significant stock price fluctuation, initially rising over 8% before closing up 6.25%, but later falling 5.88% to HKD 22.08, with a trading volume of HKD 683 million [1] Financial Performance - For the first half of 2025, Smoore International reported revenue of RMB 6.013 billion, representing a year-on-year increase of 18.3% [1] - Adjusted profit for the period was RMB 737 million, a decrease of 2.1% year-on-year [1] - Net profit for the period was RMB 492 million, reflecting a significant year-on-year decline of 27.96% [1] Dividend Announcement - In celebration of its fifth anniversary since listing, the board declared an interim dividend of HKD 0.20 per share for the six months ending June 30, 2025, compared to HKD 0.05 per share in the same period last year [1] Analyst Insights - According to a report from Bank of America Securities, the company is expected to see slight improvement in annual revenue growth, but profit margins are anticipated to remain under pressure [1]

Core Viewpoint - Smoore International (06969) experienced a significant stock price fluctuation, initially rising over 8% before closing up 6.25%, but later fell by 5.88% to HKD 22.08 with a trading volume of HKD 683 million [1] Financial Performance - For the first half of 2025, Smoore International reported revenue of RMB 6.013 billion, representing a year-on-year increase of 18.3% [1] - Adjusted profit for the period was RMB 737 million, a decrease of 2.1% year-on-year [1] - Net profit for the period was RMB 492 million, reflecting a significant year-on-year decline of 27.96% [1] Dividend Announcement - In celebration of its fifth anniversary since listing, the board declared an interim dividend of HKD 0.20 per share for the six months ending June 30, 2025, compared to HKD 0.05 per share in the same period last year [1] Analyst Insights - According to a report from Bank of America Securities, the company is expected to see slight improvement in annual revenue growth, but profit margins are anticipated to remain under pressure [1]

Investment Rating - The report maintains a "Buy" rating for the company, with a target price not specified [6]. Core Insights - The company reported a revenue of 60.13 billion yuan for the first half of 2025, representing an 18.3% year-on-year growth. Gross profit reached 22.44 billion yuan, up 16.6%, with a gross margin of 37.3%, slightly down by 0.5 percentage points. However, net profit decreased by 28.0% to 4.92 billion yuan, and adjusted net profit was 7.37 billion yuan, down 2.1% [1][5]. - The company's self-owned brand business, primarily from electronic vapor products and vapor beauty products, generated 12.74 billion yuan in revenue, a 14.1% increase, accounting for 21.2% of total revenue. The European market contributed 10.69 billion yuan, up 15.1%, while the U.S. market saw a decline of 6.7% to 1.74 billion yuan. Notably, the Chinese market surged by 2595.2% to 306.18 million yuan, driven by the sales of the vapor beauty product "Lan Zhi" [2][3]. - The company is experiencing a recovery in its vapor electronic cigarette business, supported by stricter regulations against non-compliant products in global markets. This regulatory environment is expected to sustain growth in both self-owned brand and enterprise client businesses [3][4]. Segment Summaries - **HNB Products**: The company successfully supported strategic clients in launching the high-end HNB product Hilo series, which will be launched nationwide in Japan in September 2025. The company is committed to ongoing R&D in HNB products to address user pain points [4]. - **Vapor Medical**: The subsidiary, Chuan Si Bio, is focused on developing leading generic drugs for asthma and COPD in the U.S. and Europe, with plans for further collaboration with international pharmaceutical companies [4]. - **Vapor Beauty**: The "Lan Zhi" home beauty device has surpassed 10,000 users, and the professional equipment has received Class II medical device certification, with over 100 private institutions procuring it [4]. Profit Forecast and Investment Recommendations - The company is positioned as a global leader in vapor technology solutions, with increasing competitive advantages. The report anticipates significant contributions from HNB business starting in 2026, with adjusted net profit forecasts for 2025-2027 set at 14.72 billion, 19.79 billion, and 26.63 billion yuan, respectively, reflecting year-on-year growth rates of 34.40% and 34.60% for 2026 and 2027 [5].

Group 1 - The core viewpoint of the article highlights the recent stock performance of Smoore International, which experienced a decline of 4.94% on August 22, trading at HKD 22.3 per share with a transaction volume of HKD 540 million [1] - Smoore International Holdings Limited is recognized as a global leader in aerosol technology solutions, employing nearly 20,000 staff and operating 9 research institutes worldwide, supported by a research and development team of over 1,000 [1] - As of June 30, 2021, the company has filed a total of 2,612 patents and 566 trademarks globally, with 1,272 patents and 360 trademarks granted, alongside multiple national and international certifications and honors [1] Group 2 - For the mid-term of 2025, the company plans to distribute a dividend of HKD 0.2 per share, with the ex-dividend date set for September 5, 2025, and the payment date on September 25, 2025, as per the board's proposal [2]

Core Viewpoint - The company reported strong revenue growth in the first half of the year, driven by regulatory enforcement in the US and Europe, while net profit declined due to increased non-cash share-based payments and rising operational costs [1][2][3] Financial Performance - The company achieved revenue of 6.013 billion yuan, a year-on-year increase of 18.3%, while net profit was 492 million yuan, down 28.0% year-on-year [1] - Adjusted net profit was 737 million yuan, a slight decrease of 2.1% year-on-year, aligning with previous forecasts [1] - The gross profit margin for the first half was 37.3%, a decrease of 0.5 percentage points year-on-year [3] Business Segments - The To B business segment generated revenue of 4.939 billion yuan, up 19.5% year-on-year, with significant growth in Europe and other markets [2] - The To C business segment reported revenue of 1.274 billion yuan, a year-on-year increase of 14.1%, with notable performance from the "Lan Zhi" brand in China [2] - The HNB (Heat-not-Burn) business is progressing as planned, with product launches in Serbia and Sendai, Japan, expected to expand further [3] Cost and Expenses - The increase in share-based payments contributed to a rise in management expense ratios, while R&D expense ratios decreased [3] - Distribution and sales expenses rose due to increased marketing efforts for the company's own brands and global expansion [3] Future Outlook - The company anticipates continued recovery in its core vaporization business, supported by improving regulatory frameworks in the US and Europe [1][2] - The introduction of new HNB products is expected to open a second growth curve for the company [3] Profit Forecast and Valuation - Profit forecasts have been adjusted downward due to the impact of share-based payments, with expected net profits for 2025-2027 at 1.007 billion, 1.830 billion, and 2.559 billion yuan respectively [3] - The target price for the company's stock is set at 27.00 HKD, based on a 71 times PE ratio for 2026 [3]